Biotech Investors & VC Firms in Russia
19 firms in this list, with a median first check of $50K. Generated from verified public data and updated continuously.
Skolkovo–VTB Startup Academy
MoscowPre-Seed–Seed
15 people
Kama Flow
MoscowSeed–Growth
4 people
Skolkovo Startup Academy / accelerator
MoscowPre-Seed–Seed
10 people
GenerationS
MoscowSeed–Growth
Skolkovo Foundation
MoscowPre-Seed–Seed
5 people
Mendeleev.Restart
MoscowPre-Seed–Seed$20K – $100K
Industrial Development Fund (FRP)
Seed–Series A$62.5K – $25M
RUSNANO
MoscowSeed–Series A
1 person
Unicorn Capital Partners
1 person
Mendeleev Venture Capital
MoscowPre-Seed–Seed
1 person
Artgen Seed Fund
Pre-Seed–Seed
Foundation for Assistance to Small Innovative Enterprises (FASIE / Bortnik Fund)
Pre-Seed–Seed
MIPT Startup Studio
Pre-Seed–Seed
ROSBIOTECH Startup Studio
Pre-Seed–Seed
SechenovTech
Pre-Seed–Seed
UMNIK Accelerator
Pre-Seed
University Venture Fund — KAMA FLOW
Pre-Seed–Seed
University Venture Fund — Voskhod
Pre-Seed–Seed
Amadeus Capital Partners
LondonPre-Seed–Growth$50K – $12.7M
28 people
Frequently asked questions
- Who are the top biotech investors & vc firms in russia?
- Top biotech investors & vc firms in russia include Skolkovo–VTB Startup Academy, Kama Flow, Skolkovo Startup Academy / accelerator, GenerationS, Skolkovo Foundation, Mendeleev.Restart, Industrial Development Fund (FRP), RUSNANO — 19 firms in total meet the criteria.
- What is the typical first check among biotech investors & vc firms in russia?
- The median first check among the 19 biotech investors & vc firms in russia tracked here is $50K.
Related lists
Investors & VC Firms in North America (13062)Investors & VC Firms in United States (12085)Investors & VC Firms in Europe (5940)Investors & VC Firms in Global (4992)AI & Machine Learning Investors & VC Firms (4962)Fintech Investors & VC Firms (4830)Healthtech Investors & VC Firms (4388)SaaS Investors & VC Firms (4361)Enterprise Software Investors & VC Firms (4268)Crypto & Web3 Investors & VC Firms (4044)
Data sourced from public filings and firms' own websites — see our methodology.






